Probo Medical, a supplier of new and refurbished diagnostic imaging equipment and parts, is taking a larger stake in the North American nuclear medicine, CT, and PET/CT markets via the acquisition of Alpha Source.

Founded in 1986, Alpha Source facilitates technical field service, depot repair, equipment refurbishment and resale services, and parts distribution for OEMs, ISOs, asset managers, hospitals, distributors, and resellers. Its subsidiaries include Alpha Source Biomed Solutions, BC Technical Imaging Solutions, and Medical Optics Surgical Solutions.

The company has more than 100 field service engineers, and in-house personnel who manage its four Centers of Excellence in Salt Lake City, Utah; Jeffersonville, Indiana; Tamarac, Florida; and Milwaukee, Wisconsin. These centers facilitate repairs, refurbishment, parts harvesting, and distribution of nuclear medicine, PET, CT, MR, PET/CT, ultrasound, bone mineral density, medical batteries, biomedical devices, and other multimodality medical equipment.

Probo, which also provides rental, installation, and repair services, has built up a scalable platform in the ultrasound market and is looking to expand it with Alpha Source, signing a definitive purchase agreement with the company.

“Probo is a global leader in system procurement across the aforementioned modalities. Integrating that proficiency with Alpha Source's technical capabilities will quickly allow us to expand parts harvest and distribution, scale system refurbishment and resale, and optimize our ability to deliver best-in-class field service with a global team of over 350 field service engineers,” said Michael Asmer, CEO of Probo, in a statement.

Earlier this year, Probo Medical acquired National Ultrasound and Ultra Select as components of its ultrasound platform.

It also services C-arm, X-ray, mammography, fluoroscopy, CT, and MR equipment, and recently purchased the MR coil repair operation from Creative Foam, a company specializing in the design, engineering, and manufacturing of a range of solutions in the transportation and healthcare markets.

It is backed by Avista Capital Partners, a private equity firm focused exclusively on healthcare with over $8 billion invested in more than 45 growth-oriented healthcare businesses worldwide.

Financial details were not disclosed. A timeline for the completion of the deal was also not provided.

Back to HCB News

Business Affairs Homepage